New AI-Based Method Supports Acute Myeloid Leukemia Diagnosis
An AI-based solution may help predict various genetic features based on microscopic images of bone marrow smears to improve AML diagnosis.
Read MorePosted by Andy Lundin | Jan 9, 2024 | Leukemia |
An AI-based solution may help predict various genetic features based on microscopic images of bone marrow smears to improve AML diagnosis.
Read MorePosted by Andy Lundin | Dec 29, 2023 | Unknown Origin & Other Cancer Types |
Researchers wanted to see if a liquid biopsy tool could capture and isolate CTCs in blood samples taken from children with CNS tumors.
Read MorePosted by Andy Lundin | Dec 7, 2023 | Hematology Instrumentation |
The hematology analyzer provides patient-side results to screen for conditions including infection, leukemia, and other blood-related cancers.
Read MorePosted by Andy Lundin | Dec 4, 2023 | Lab Automation, Unknown Origin & Other Cancer Types |
Beckman Coulter Life Sciences received 510(k) clearance from the FDA to distribute its AQUIOS STEM System in the United States.
Read MorePosted by Chris Wolski | Nov 16, 2023 | Diagnostic Technologies |
Consolidation, legislation, new testing types, and a shift to more consumer-driven testing are some clinical laboratory predictions for 2024.
Read More